Cargando…

Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis

BACKGROUND & AIMS: Altered gut microbiota is associated with poor outcomes in cirrhosis, including infections and hepatic encephalopathy (HE). However, the role of bacterial virulence factors (VFs) is unclear. Aim: Define association of VFs with cirrhosis severity and infections, their linkage w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Jasmohan S, Shamsaddini, Amirhossein, Acharya, Chathur, Fagan, Andrew, Sikaroodi, Masoumeh, Gavis, Edith, McGeorge, Sara, Khoruts, Alexander, Fuchs, Michael, Sterling, Richard K, Lee, Hannah, Gillevet, Patrick M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582993/ https://www.ncbi.nlm.nih.gov/pubmed/34743650 http://dx.doi.org/10.1080/19490976.2021.1993584

Ejemplares similares

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study
por: Acharya, Chathur, et al.
Publicado: (2021)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers
por: Shaw, Jawaid, et al.
Publicado: (2023)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

Transmitting Diet‐Related Microbial Benefit through Fecal Microbiota Transplant in NASH: Can Microbiota Cut Through the Fat?
por: Acharya, Chathur, et al.
Publicado: (2020)

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
por: Zhang, Yuan, et al.
Publicado: (2021)

Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
por: Wolstenholme, Jennifer T., et al.
Publicado: (2022)

Gut Microbiota as Biosensors in Patients With Cirrhosis
por: Bajaj, Jasmohan S.
Publicado: (2019)

BiomMiner: An advanced exploratory microbiome analysis and visualization pipeline
por: Shamsaddini, Amirhossein, et al.
Publicado: (2020)

Whoop there it is: decoding sleep, cirrhosis, and HE
por: Badal, Bryan D., et al.
Publicado: (2023)

A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
por: Nadeem, Mahum, et al.
Publicado: (2023)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model
por: Saunders, Justin M., et al.
Publicado: (2020)

The Presence of Denitrifiers In Bacterial Communities of Urban Stormwater Best Management Practices (BMPs)
por: Hall, Natalie C., et al.
Publicado: (2021)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome
por: Brown, Robert E., et al.
Publicado: (2015)

Temporal Study of the Microbial Diversity of the North Arm of Great Salt Lake, Utah, U.S.
por: Almeida-Dalmet, Swati, et al.
Publicado: (2015)

Optimization of tissue sampling for Borrelia burgdorferi in white-footed mice (Peromyscus leucopus)
por: Zawada, Sonya G., et al.
Publicado: (2020)

Genetic variation of Borreliella burgdorferi in Fairfax County, Virginia, targeting the OspC gene in white-footed mice
por: Zawada, Sonya G., et al.
Publicado: (2022)

Effect of Increasing Age on Brain Dysfunction in Cirrhosis
por: Liu, Runping, et al.
Publicado: (2018)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
por: Kang, Dae Joong, et al.
Publicado: (2017)

Sa1372: TRACKING CIRRHOSIS CARE DURING COVID-19 PANDEMIC
por: Adejumo, Adeyinka C., et al.
Publicado: (2022)

Tu1264: PATIENTS WITH CIRRHOSIS EXPERIENCE HIGHER ICU MORTALITY COMPARED TO NON-CIRRHOTIC PATIENTS WHICH CONTINUED WITH OR WITHOUT COVID-19 DESPITE CONTROLLING FOR ORGAN FAILURE SEVERITY
por: Park, Dan, et al.
Publicado: (2022)

Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals
por: Ghannoum, Mahmoud A., et al.
Publicado: (2010)

Characterizing patient-reported outcomes in veterans with cirrhosis
por: Rogal, Shari S., et al.
Publicado: (2020)

The Approach to Sample Acquisition and Its Impact on the Derived Human Fecal Microbiome and VOC Metabolome
por: Couch, Robin D., et al.
Publicado: (2013)

Gut microbiome identifies risk for colorectal polyps
por: Dadkhah, Ezzat, et al.
Publicado: (2019)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Adventures in Developing an App for Covert Hepatic Encephalopathy
por: Bajaj, Jasmohan S
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h96q7j9002golpe24rppce8gtj